Clinical Trial Update: A Phase IIa Study to Evaluate NBQ72S [Phase 2]

View source ↗

Summary

A Phase IIa study to evaluate NBQ72S in breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• NBQ72S

Snippet

Sponsor: Nantong Bencao Quadriga Medical Technology Co. Ltd. | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING